Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.

NEW YORK, February 04, 2025 -- ( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and ...

Operator Good day, everyone and welcome to Pfizer's fourth-quarter 2024 earnings conference call. Today's call is being ...

Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon , lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan said on ...

On behalf of the Pfizer team, thank you for joining us ... And in January of '25, we monetized another tranche of our Haleon shares, which for reporting purposes is a Q1 '25 event.

The anticipation surrounding dose optimization data for Pfizer (NYSE:PFE)'s obesity treatment, danuglipron, was also mentioned as a point of interest for the first quarter. However, the analyst ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...